Onyx Pharmaceuticals to Present at Jefferies 2nd Annual Healthcare Conference

Friday, June 20, 2008 General News J E 4
EMERYVILLE, Calif., June 19 OnyxPharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will present atthe Jefferies 2nd Annual Healthcare Conference on Thursday, June 26, at10:45 a.m. Eastern Time. Interested parties may access a live webcast of thepresentation on our website at:

It is recommended that listeners log on 15 minutes early in order toregister and download any necessary software. For those unable to participateduring the live webcast, a recorded replay of the presentation will beavailable within 24 hours of the completion of the presentation through July26, 2008.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed toimproving the lives of people with cancer by changing the way cancer istreated(TM). The company, in collaboration with Bayer HealthCarePharmaceuticals, Inc., is developing and marketing Nexavar(R), a smallmolecule drug. Nexavar is currently approved for the treatment of livercancer and advanced kidney cancer. Additionally, Nexavar is beinginvestigated in several ongoing trials in non-small cell lung cancer,melanoma, breast cancer, and other cancers. For more information about Onyx,visit the company's website at

Nexavar(R) (sorafenib) tablets is a registered trademark of BayerPharmaceuticals Corporation.

SOURCE Onyx Pharmaceuticals, Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Baxter Releases Ninth Annual Sustainability Report
Regence Pilot Shows Affordability of Electronic Me...